Alphabet and GSK create $715 million bioelectronics firm
0
GlaxoSmithKline and Alphabet's life sciences unit are creating a new company focused on fighting diseases.
GlaxoSmithKline and Alphabet's life sciences unit are creating a new company focused on fighting diseases.